Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29243279 | 0.88 | CA2 (0.35) | CA2 | |
| SCHEMBL16411313 | 0.78 | ALDH1A1 (0.37) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL16683752 | 0.77 | ALDH1A1 (0.40) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL28756467 | 0.77 | ALDH1A1 (0.36) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL16439971 | 0.77 | ALDH1A1 (0.36) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL20983995 | 0.76 | CYP3A4 (0.39) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL18826021 | 0.76 | HPGD (0.36) | HTTALDH1A1CYP3A4SMN1; SMN2CA2 | |
| SCHEMBL725427 | 0.76 | TSHR (0.35) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL18825932 | 0.74 | PTGS2 (0.40) | ALDH1A1CYP3A4CA2KDM4ETHRB | |
| SCHEMBL3904764 | 0.74 | ALDH1A1 (0.32) | TSHRALDH1A1CYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111269246-B | Dibromo compound containing thiophene and thiazole [4,5, b ] thiazole structure and preparation method thereof | 江汉大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-111269246-A | Dibromo compound containing thiophene and thiazole [4,5, b ] thiazole structure and preparation method thereof | 江汉大学 | 2020-06-12 | — | — | CN | disclosed |
| US-8673183-B2 | Tetrazine monomers and copolymers for use in organic electronic devices | NATIONAL RESEARCH COUNCIL OF CANADA | 2014-03-18 | — | — | US | disclosed |
| US-20120007026-A1 | TETRAZINE MONOMERS AND COPOLYMERS FOR USE IN ORGANIC ELECTRONIC DEVICES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120007026-A1 | TETRAZINE MONOMERS AND COPOLYMERS FOR USE IN ORGANIC ELECTRONIC DEVICES | CCNE1, CCNE2, WEE1 | TSHR 2462/4885L3MBTL1 4857/4885GLA 4789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.